SILODOSIN
NDC 59651-095, SILODOSIN, capsule, from Aurobindo Pharma Limited.
- Product NDC
- 59651-095
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210626
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILODOSIN4 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-095-30 | 59651009530 | 30 CAPSULE in 1 BOTTLE (59651-095-30) |
| 59651-095-90 | 59651009590 | 90 CAPSULE in 1 BOTTLE (59651-095-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5e5038ea-9214-469b-8174-e5787be7a801NADAC price for package 59651009530
GET /v1/drugs/nadac/59651009530
Use it
Look up 59651-095 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-095. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.